Navigation Links
Establishing the Correct QbD Strategies and Tools Early in the Development Process is Key to Ensuring we Have Robust Quality Products Downstream
Date:10/11/2011

LONDON, October 11, 2011 /PRNewswire/ --

PAT and QbD remains a field that still lacks clarity and commonality in understanding. In a recent industry-survey released by Pharma IQ across the PAT and QbD community it was  found that 53% of end users said the key reason they were not implementing PAT/QbD was due to a lack of personnel with expertise in the field.

However, Pharma IQ once again opens its doors to industry specialists from the PAT and QbD community and creates an opportunity to learn from leading minds in the industry, increase understanding in companies and cut costs and increase efficiency by learning the best practice approaches to implementing PAT and QbD at  the 9th Annual PAT and QbD conference on the 20 - 22 February, 2012, Thistle Marble Arch, London, UK.

For full event information visit: http://www.patandqbd.com/news

Brett Cooper, Research Fellow, MSD Development Laboratories will be speaking at the conference about PAT and QbD within the early development space. On this he mentions: "This is becoming an increasingly important area of interest within MSD."

Nuno Matos, a PAT Specialist from Hovione is also speaking at this industry event and he adds: "I also look forward to discussing the role of the CMO in the integration of QbD/PAT methodologies across the drug substance and drug product supply chain during development and commercial manufacturing."

Furthermore, the conference agenda includes a number of regulatory orientated talks, opportunities to speak directly with regulators during interactive panel discussions and a fantastic panel of speakers with perspectives offered by 3 regulatory bodies.

Find the full program, event details and registration information on http://www.patandqbd.com/news or email enquire@iqpc.co.uk

Media contact: Veronica Araujo, +44(0)20-7368-9748, veronica.araujo@iqpc.co.uk or visit http://www.patandqbd.com/news

Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Veronica Araujo (veronica.araujo@iqpc.co.uk)



'/>"/>
SOURCE Pharma IQ
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. The Immune Tolerance Institute and David H. Murdock Research Institute Announce a Partnership Establishing a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
2. Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market
3. VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
4. BioMarin Corrects Information Included in Bloomberg Article
5. Corrected: XTL Biopharmaceuticals to Convene Extraordinary Shareholders Meetings after Receipt of Shareholder Letter
6. The Holtorf Medical Group and Yan Center for Corrective & Cosmetic Surgery Tap 5W Public Relations
7. Rick Fraunfelder, M.D. of the Casey Vision Correction Center in Portland, Oregon, Joins Elite Group of Surgeons Listed at Trusted LASIK Surgeons
8. Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory
9. LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting
10. Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P. Gailitis, M.D., F.A.C.S.
11. Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, ... faculty of the University of North Carolina Kenan-Flagler Business School effective ... at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):